NIH-funded research R01 grant

Investigating the role of gut bacteria and immune cells in autoimmune eye disease

Official title: Intestinal T cells and microbiota as therapeutic targets in autoimmune uveitis

Funded at Cleveland Clinic Lerner Com-Cwru · NIH-10877091 · Data updated 2026-11-12

This study is looking at how the bacteria in your gut might affect autoimmune uveitis, a condition that can cause vision problems, and it hopes to find new ways to help improve eye health by changing gut bacteria through diet and antibiotics.

More Microbiota research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCleveland Clinic Lerner Com-Cwru
NIH-funded
Lab location1 site (Cleveland, United States)
Project startSeptember 1, 2021
Project endJune 30, 2026
Funding year2024
Award (this year)$525,129
NIH project number5R01EY032882-05
Project IDNIH-10877091 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with autoimmune uveitis who may not respond well to traditional anti-inflammatory treatments.

Less likely to help

Patients with uveitis caused by non-autoimmune factors or those who do not have an active disease may not benefit from this research.

What this research studies

This research focuses on understanding how the gut microbiota influences autoimmune uveitis, a condition that can lead to blindness. By manipulating gut bacteria through antibiotics and dietary components, the study aims to restore immune balance in the body. Patients may benefit from new therapeutic strategies that target the gut to improve eye health and reduce inflammation. The research employs a model of experimental autoimmune uveitis to explore these interventions and their effects on immune cells.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that specifically target the gut microbiome to alleviate symptoms of autoimmune uveitis and prevent vision loss.

How similar studies have gone: Previous research has shown promising results in manipulating the gut microbiome to influence autoimmune conditions, suggesting potential for success in this novel approach.

Where this research is happening

  • Cleveland Clinic Lerner Com-Cwru
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Lin, Phoebe — Cleveland Clinic Lerner Com-Cwru
  • Study coordinator: Lin, Phoebe

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.